Healthy Beginnings for Body Weight

Phase-Based Estimates
1
Effectiveness
1
Safety
Pennington Biomedical Research Center, Baton Rouge, LA
Body Weight+2 More
Healthy Beginnings - Behavioral
Eligibility
18 - 65
Female
Eligible conditions
Body Weight

Study Summary

This study is evaluating whether a smartphone app can help improve the health of women and children in a state-wide program.

See full description

Eligible Conditions

  • Body Weight
  • Weight Gain
  • Weight Gain During Pregnancy

Treatment Effectiveness

Effectiveness Estimate

1 of 3

Study Objectives

This trial is evaluating whether Healthy Beginnings will improve 1 primary outcome and 2 secondary outcomes in patients with Body Weight. Measurement will happen over the course of Approximately 6 months (from 10-16 weeks gestation to 35-38 weeks gestation).

Month 6
Gestational Weight Gain Per Week
Number of Women Who Have Excess Gestational Weight Gain
Total Gestational Weight Gain

Trial Safety

Trial Design

2 Treatment Groups

Control
Healthy Beginnings

This trial requires 432 total participants across 2 different treatment groups

This trial involves 2 different treatments. Healthy Beginnings is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Healthy Beginnings
Behavioral
Participants will receive the SmartMoms smartphone application, a wireless connected scale, and a Fitbit. The Healthy Beginnings program includes a 24 week intensive behavior modification program that targets healthy gestational weight gain through self-monitoring of weight and activity data, automated prescriptive feedback from the SmartMoms smartphone application, personalized feedback from counselors, and evidence-based behavioral intervention delivered throughout pregnancy.
ControlNo treatment in the control group

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: approximately 6 months (from 10-16 weeks gestation to 35-38 weeks gestation)
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly approximately 6 months (from 10-16 weeks gestation to 35-38 weeks gestation) for reporting.

Who is running the study

Principal Investigator
L. R.
Prof. Leanne Redman, Professor
Pennington Biomedical Research Center

Closest Location

Pennington Biomedical Research Center - Baton Rouge, LA

Eligibility Criteria

This trial is for female patients between 18 and 65 years old. There are 6 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
The fetus is less than 16 weeks gestational age if the screening visit is the first prenatal visit. show original
This person is eligible to receive services from the Women, Infants, and Children program during their current pregnancy. show original
become a requirement for most people? Many people believe that having a smartphone with internet access has become a requirement for most people. show original
You should have a BMI of between 18.5 and 40 kg/m2. show original
Expecting a singleton pregnancy
I am willing to be identifiable to other study participants in this study program. show original

Patient Q&A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people get body weight a year in the United States?

Add answer

Although the incidence of obesity in the United States has increased in the past 2 decades, the majority of Americans have low BMI. For this group of individuals, lifestyle improvements may reduce obesity rates at least as greatly as calorie-control dieting and exercising may for those with a BMI of 25 kg/m².

Unverified Answer

What causes body weight?

Add answer

We investigated what it meant to be overweight and whether different factors might explain this discrepancy between health professionals and patients. Results from a recent paper will be useful for health professionals, health promotion workers and patients alike.

Unverified Answer

What are common treatments for body weight?

Add answer

Treatment decisions for body weight are complicated by an individual patient's condition as well as by the side effects of treatment. When counseling a patient about treatment, it is important to first identify factors that may be contributing to difficulty in maintaining weight loss or achieving a gain. Common approaches include behavioral interventions, weight reduction, exercise, medications to control appetite, and weight maintenance.

Unverified Answer

Can body weight be cured?

Add answer

We have demonstrated that overweight individuals who are able to achieve and maintain a weight within BMI target range have the lowest risk of developing cancer.

Unverified Answer

What is body weight?

Add answer

The majority of women and men who are obese perceive their weight as unhealthy and would like to lose weight; however, the majority of the population is not able to maintain their weight loss goals and is not satisfied with their weight status.

Unverified Answer

What are the signs of body weight?

Add answer

Obesity presents as the most important sign for detecting a high risk group, in which all persons need more preventive measures. Fatty liver disease is a marker for risk of future metabolic disorders. It could be an independent risk factor for the development of type 2 diabetes.

Unverified Answer

Has healthy beginnings proven to be more effective than a placebo?

Add answer

The present study indicates that for healthy weight participants, a weight control plan composed of four to six sessions with a supervised fitness instructor of regular weight and an attendance of regular fitness classes that take into account the participants' physical abilities is feasible and effective in reducing body weight. Results support an effect that does not depend on compliance and suggests that weight control is a simple, affordable intervention that is not only effective for weight loss, but may also affect some of the well-known cardiovascular health-related risk factors.

Unverified Answer

What is the latest research for body weight?

Add answer

[Body weight fluctuation, age, gender and BMI are 4 main factors that influence body weight changes]{http://www.physiological-behavio[ra](https://www.withpower.com/clinical-trials/ra)l-basis.com/fitness/factors/[overweight](https://www.withpower.com/clinical-trials/overweight).html}. The most recent research has found that a [5-kgram (25-lb) overweight person's BMI rises by 1-point and an underweight person's BMI rises by 4-point, so the average BMI range is between 23 and 25. However, BMI is a relative-value indicator of fat-mass percentage while calculating a person's body fat percentage (FTF). The most recent research has been to use the method that calculates FTF as the most accurate.

Unverified Answer

What is healthy beginnings?

Add answer

Healthy beginnings encourages parents to recognize the early signs and symptoms and initiate routine check-ups of their child's growth and development. More importantly, early identification and treatment of any problems would avert long-term adverse health effects.

Unverified Answer

Who should consider clinical trials for body weight?

Add answer

A growing body of evidence now demonstrates that obese individuals benefit from weight loss or maintenance in managing chronic disease as obese adults fare worse on many measures of quality of life than their less-obese counterparts.

Unverified Answer

What is the average age someone gets body weight?

Add answer

The present study shows that the average age that men and women begin to attain body weights that are normal or prehypertensive is 13 years younger for men than for women (13.4 years vs. 15.7 years, respectively, P < 0.001).

Unverified Answer

Have there been any new discoveries for treating body weight?

Add answer

In fact most available drug therapies may promote body weight gain. However even if clinical studies are undertaken to search for new compounds, many of them are very expensive because of the long time required to go through the preclinical phase while a new compound has to be introduced into the market or have an equivalent one. In this regard, as of 2014 few compounds from synthetic chemistry have been studied because the synthesis of many potential drugs are very expensive and many of them are difficult to obtain because of structural complexity and/or synthetic difficulties. In any case, it is very common that a company will decide to develop a drug that could also be considered a natural product of a fungal species, a plant species or as part of a bacterial species, etc.

Unverified Answer
See if you qualify for this trial
Get access to this novel treatment for Body Weight by sharing your contact details with the study coordinator.